Yisheng Biopharma, a biopharmaceutical company focusing on research, development, manufacturing, sales and marketing of immunological biologics and vaccines, said that its new rabies vaccine production facility has received a Pharmaceutical GMP Certificate from the China National Medical Products Administration (NMPA) for production of its Yisheng Junan product, the first lyophilized rabies vaccine without an aluminum adjuvant produced in China for medical use. The Yisheng Junan vaccine has been...